531633 Stock Overview
Engages in manufacturing and trading of pharmaceutical products in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Lincoln Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹617.50 |
| 52 Week High | ₹814.00 |
| 52 Week Low | ₹498.00 |
| Beta | 0.68 |
| 11 Month Change | -4.60% |
| 3 Month Change | -13.68% |
| 1 Year Change | -2.46% |
| 33 Year Change | 87.60% |
| 5 Year Change | 259.43% |
| Change since IPO | 2,472.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| 531633 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0.5% | 0.5% | 0.5% |
| 1Y | -2.5% | 42.5% | 27.5% |
Return vs Industry: 531633 underperformed the Indian Pharmaceuticals industry which returned 42.5% over the past year.
Return vs Market: 531633 underperformed the Indian Market which returned 27.5% over the past year.
Price Volatility
| 531633 volatility | |
|---|---|
| 531633 Average Weekly Movement | 4.5% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 531633 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 531633's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 1,687 | Mahendrabhai Patel | www.lincolnpharma.com |
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It also exports its products to approximately 60 countries, including Europe, Canada, Latin and North America, Africa, the Asia Pacific, and South East Asia.
Lincoln Pharmaceuticals Limited Fundamentals Summary
| 531633 fundamental statistics | |
|---|---|
| Market cap | ₹12.37b |
| Earnings (TTM) | ₹966.39m |
| Revenue (TTM) | ₹5.97b |
12.8x
P/E Ratio2.1x
P/S RatioIs 531633 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531633 income statement (TTM) | |
|---|---|
| Revenue | ₹5.97b |
| Cost of Revenue | ₹2.87b |
| Gross Profit | ₹3.10b |
| Other Expenses | ₹2.13b |
| Earnings | ₹966.39m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 48.25 |
| Gross Margin | 51.90% |
| Net Profit Margin | 16.18% |
| Debt/Equity Ratio | 0.2% |
How did 531633 perform over the long term?
See historical performance and comparison